Education
About Us
Working with TipRanks
Follow Us
Santen Pharmaceutical (SNPHY)
:SNPHY
RESEARCH TOOLSreports
SNPHY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$8.88 - $12.89
Previous CloseN/A
Volume180.00
Average Volume (3M)35.00
Market Cap
$3.90B
Enterprise Value$473.85B
Total Cash (Recent Filing)$93.99B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)16.7
Beta0.09
Next Earnings
Aug 07, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 28, 2023Dividend Yield1.32%
Share Statistics
EPS (TTM)0.17
Shares Outstanding342,059,540
10 Day Avg. Volume0
30 Day Avg. Volume35
Financial Highlights & Ratios
PEG Ratio0.48
Price to Book (P/B)1.99
Price to Sales (P/S)0.00
P/FCF Ratio10.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.01% Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
SNPHY FAQ
What was Santen Pharmaceutical’s price range in the past 12 months?
Santen Pharmaceutical lowest stock price was $8.88 and its highest was $12.89 in the past 12 months.
What is Santen Pharmaceutical’s market cap?
Santen Pharmaceutical’s market cap is $3.90B.
When is Santen Pharmaceutical’s upcoming earnings report date?
Santen Pharmaceutical’s upcoming earnings report date is Aug 07, 2025 which is in 12 days.
How were Santen Pharmaceutical’s earnings last quarter?
Santen Pharmaceutical released its earnings results on May 13, 2025. The company reported $0.169 earnings per share for the quarter, beating the consensus estimate of N/A by $0.169.
Is Santen Pharmaceutical overvalued?
According to Wall Street analysts Santen Pharmaceutical’s price is currently Overvalued.
Does Santen Pharmaceutical pay dividends?
Santen Pharmaceutical pays a Semiannually dividend of $0.076 which represents an annual dividend yield of 1.32%. See more information on Santen Pharmaceutical dividends here
What is Santen Pharmaceutical’s EPS estimate?
Santen Pharmaceutical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Santen Pharmaceutical have?
Santen Pharmaceutical has 342,059,540 shares outstanding.
What happened to Santen Pharmaceutical’s price movement after its last earnings report?
Santen Pharmaceutical reported an EPS of $0.169 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.627%.
Which hedge fund is a major shareholder of Santen Pharmaceutical?
Currently, no hedge funds are holding shares in SNPHY
Santen Pharmaceutical Co Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-2.02%
12-Months-Change
Fundamentals
Return on Equity
12.06%
Trailing 12-Months
Asset Growth
-4.93%
Trailing 12-Months
Company Description
Santen Pharmaceutical
Santen Pharmaceutical Co., Ltd. is a Japanese company specializing in the research, development, production, and marketing of ophthalmic products. Established in 1890, Santen has grown to become a leading company in the eye care sector, providing a wide range of pharmaceutical solutions for various eye diseases and conditions. The company's core products include prescription ophthalmic pharmaceuticals, over-the-counter eye care products, and medical devices related to eye health.